thiophenes has been researched along with Bone Neoplasms in 18 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 7 (38.89) | 29.6817 |
2010's | 7 (38.89) | 24.3611 |
2020's | 4 (22.22) | 2.80 |
Authors | Studies |
---|---|
Duvall, CL; Guelcher, SA; Gupta, MK; Johnson, RW; Kwakwa, KA; Merkel, AR; Rhoades, JA; Vanderburgh, JP; Werfel, TA | 1 |
Bedingfield, SK; d'Arcy, R; Duvall, CL; Guelcher, SA; Gupta, MK; Hill, JL; Kwakwa, KA; Merkel, AR; Moyer, K; Rhoades, JA; Vanderburgh, J; Wang, SK | 1 |
Bedoya, CAF; Buzbee, M; Harden, A; Marmonti, E; Morrell, MG; Savage, H; Schadler, K; Zhang, A | 1 |
Dean, DC; Duan, Z; Hornicek, FJ; Nelson, SD; Thanindratarn, P | 1 |
Dadwal, UC; Kessler, M; Kwakwa, KA; Merkel, AR; Page, JM; Rhoades, JA | 1 |
Cui, JH; Ju, J; Yoon, MH | 1 |
Bogado, RF; Brassesco, MS; de Oliveira, HF; Pezuk, JA; Tone, LG | 1 |
Baranski, Z; Booij, TH; Bovée, JV; Cleton-Jansen, AM; Danen, EH; Hogendoorn, PC; Price, LS; van de Water, B | 1 |
Chirgwin, JM; Suvannasankha, A | 1 |
Akram, MM; Bisht, K; Brogi, E; Camphausen, K; Degenhardt, YY; Edelman, DC; Hua, E; Killian, JK; Lampkin, TA; Laquerre, S; Liewehr, DJ; Meltzer, PS; Palmieri, D; Pineda, M; Qian, Y; Scurci, S; Skordos, KW; Steeg, PS; Steinberg, SM; Woditschka, S | 1 |
Guo, W; Tang, BQ; Tang, S; Tang, XD; Yan, TQ; Yang, RL | 1 |
Bjarnason, GA; Charpentier, D; Dent, S; Douglas, L; Goel, R; Matthews, S; Seymour, L; Walsh, W; Winquist, E; Wong, R | 1 |
Cooper, RD; Daniel-Issakani, S; Goff, D; Goldstein, E; Gururaja, TL; Hitoshi, Y; Huang, J; Kinoshita, T; McLaughlin, J; Pali, E; Payan, DG; Singh, R; Yung, S | 1 |
Cremers, S; Garnero, P | 1 |
Bone, E; Lee, J; Mejia, S; Orr, W; Watson, P; Weber, M | 1 |
Anderson, RL; Bissell, MJ; Le Beyec, J | 1 |
Bhagat, S; Che, M; Cher, ML; Fridman, R; Herzog, M; Mullins, C; Nemeth, JA; Shekarriz, B; Upadhyay, J; Yousif, R | 1 |
Andersen, TL; Brünner, N; Delaissé, JM; Foged, NT; Heegaard, AM; Holst-Hansen, C; Høegh-Andersen, P; Misander, H; NicAmhlaoibh, R; Winding, B | 1 |
2 review(s) available for thiophenes and Bone Neoplasms
Article | Year |
---|---|
Role of bone-anabolic agents in the treatment of breast cancer bone metastases.
Topics: Antineoplastic Agents; Bone Density Conservation Agents; Bone Neoplasms; Boronic Acids; Bortezomib; Breast Neoplasms; Everolimus; Female; Humans; Oligopeptides; Osteoblasts; Parathyroid Hormone; Proteasome Inhibitors; Pyrazines; Recombinant Fusion Proteins; Sirolimus; Thiophenes; Transforming Growth Factor beta | 2014 |
Biochemical markers of bone turnover in the clinical development of drugs for osteoporosis and metastatic bone disease: potential uses and pitfalls.
Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Biomarkers; Bone Density; Bone Diseases, Metabolic; Bone Neoplasms; Bone Remodeling; Bone Resorption; Calcitonin; Cathepsin K; Cathepsins; Collagen Type I; Denosumab; Diphosphonates; Drug Administration Schedule; Drug Design; Female; Humans; Organometallic Compounds; Osteitis Deformans; Osteogenesis; Osteoporosis; Osteoporosis, Postmenopausal; Parathyroid Hormone; Raloxifene Hydrochloride; RANK Ligand; Thiophenes | 2006 |
2 trial(s) available for thiophenes and Bone Neoplasms
Article | Year |
---|---|
[Evaluation of efficacy and safety of rivaroxaban in the prevention of postoperative venous thromboembolism in adult patients with primary bone tumor undergoing knee operation].
Topics: Adult; Anticoagulants; Bone Neoplasms; Female; Humans; Knee; Male; Middle Aged; Morpholines; Postoperative Complications; Prospective Studies; Rivaroxaban; Thiophenes; Treatment Outcome; Venous Thromboembolism; Young Adult | 2012 |
Phase I study of Tomudex and Doxorubicin in patients with locally advanced, inoperable or metastatic cancer (IND.98).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Doxorubicin; Female; Head and Neck Neoplasms; Humans; Liver Neoplasms; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Quinazolines; Salvage Therapy; Stomach Neoplasms; Thiophenes | 2005 |
14 other study(ies) available for thiophenes and Bone Neoplasms
Article | Year |
---|---|
Systemic delivery of a Gli inhibitor via polymeric nanocarriers inhibits tumor-induced bone disease.
Topics: Animals; Antineoplastic Agents; Apoptosis; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Carriers; Drug Liberation; Female; Gene Expression Regulation, Neoplastic; Humans; Mammary Neoplasms, Animal; Mesenchymal Stem Cells; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Nanoparticles; Osteogenesis; Polymers; Pyridines; Thiophenes; Zinc Finger Protein Gli2 | 2019 |
Tuning Ligand Density To Optimize Pharmacokinetics of Targeted Nanoparticles for Dual Protection against Tumor-Induced Bone Destruction.
Topics: Animals; Antineoplastic Agents; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Drug Screening Assays, Antitumor; Female; Humans; Ligands; Mice; Mice, Inbred C57BL; Mice, Knockout; Nanoparticles; Optical Imaging; Particle Size; Polymers; Pyridines; Surface Properties; Thiophenes; X-Ray Microtomography | 2020 |
Modulating sphingosine-1-phosphate receptors to improve chemotherapy efficacy against Ewing sarcoma.
Topics: Animals; Antibiotics, Antineoplastic; Bone Neoplasms; Capillary Permeability; Cell Line, Tumor; Doxorubicin; Endothelial Cells; Humans; Mice, Nude; Oxadiazoles; Pyrazoles; Pyridines; Sarcoma, Ewing; Sphingosine 1 Phosphate Receptor Modulators; Sphingosine-1-Phosphate Receptors; Thiophenes; Treatment Outcome; Xenograft Model Antitumor Assays | 2020 |
T-LAK cell-originated protein kinase (TOPK) is a Novel Prognostic and Therapeutic Target in Chordoma.
Topics: Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Chordoma; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Mitogen-Activated Protein Kinase Kinases; Neoplasm Metastasis; Prognosis; Protein Kinase Inhibitors; Quinolones; RNA Interference; RNA, Small Interfering; Thiophenes | 2020 |
3D Bone Morphology Alters Gene Expression, Motility, and Drug Responses in Bone Metastatic Tumor Cells.
Topics: Animals; Bone Neoplasms; Cell Line, Tumor; Cell Movement; Female; Gene Expression Regulation, Neoplastic; Humans; Mice; Mice, Nude; Models, Biological; Neoplasm Metastasis; Neoplasm Proteins; Pyridines; Thiophenes; Tissue Scaffolds | 2020 |
Pharmacology of cannabinoid receptor agonists and a cyclooxygenase-2 inhibitor in rat bone tumor pain.
Topics: Animals; Arachidonic Acids; Bone Neoplasms; Cannabinoid Receptor Agonists; Cannabinoids; Cell Line, Tumor; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Female; Hyperalgesia; Pain; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; RNA, Messenger; Spinal Cord; Thiophenes; Tibia | 2013 |
BI 6727 and GSK461364 suppress growth and radiosensitize osteosarcoma cells, but show limited cytotoxic effects when combined with conventional treatments.
Topics: Antineoplastic Agents; Apoptosis; Benzimidazoles; Bone Neoplasms; Cell Cycle Checkpoints; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Humans; Osteosarcoma; Polo-Like Kinase 1; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Pteridines; Radiation Tolerance; Radiation-Sensitizing Agents; Thiophenes | 2015 |
Aven-mediated checkpoint kinase control regulates proliferation and resistance to chemotherapy in conventional osteosarcoma.
Topics: Adaptor Proteins, Signal Transducing; Antibiotics, Antineoplastic; Apoptosis; Apoptosis Regulatory Proteins; Ataxia Telangiectasia Mutated Proteins; Bone Neoplasms; Cell Line, Tumor; Checkpoint Kinase 1; DNA Damage; Doxorubicin; G2 Phase Cell Cycle Checkpoints; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Membrane Proteins; Oligonucleotide Array Sequence Analysis; Osteosarcoma; Phosphorylation; Protein Kinases; RNA Interference; Signal Transduction; Thiophenes; Urea | 2015 |
Inhibition of Polo-like kinase 1 prevents the growth of metastatic breast cancer cells in the brain.
Topics: Animals; Bone Neoplasms; Brain Neoplasms; Breast Neoplasms; Cell Cycle Proteins; Cell Proliferation; Female; Humans; Immunoenzyme Techniques; Lung Neoplasms; Mice; Polo-Like Kinase 1; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Radiation, Ionizing; Survival Rate; Thiophenes; Tissue Array Analysis; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2011 |
R-253 disrupts microtubule networks in multiple tumor cell lines.
Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Bone Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Survival; Colonic Neoplasms; Flow Cytometry; HeLa Cells; Humans; Lung Neoplasms; Microtubules; Molecular Weight; Osteosarcoma; Pyrimidines; Thiophenes; Thiourea | 2006 |
A matrix metalloproteinase inhibitor, batimastat, retards the development of osteolytic bone metastases by MDA-MB-231 human breast cancer cells in Balb C nu/nu mice.
Topics: Animals; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Humans; Matrix Metalloproteinase Inhibitors; Mice; Mice, Inbred BALB C; Phenylalanine; Thiophenes; Tumor Cells, Cultured | 2001 |
Prostate cancer in bone: importance of context for inhibition of matrix metalloproteinases.
Topics: Animals; Antineoplastic Agents; Bone Neoplasms; Disease Models, Animal; Humans; Male; Matrix Metalloproteinase Inhibitors; Neoplasm Metastasis; Phenylalanine; Prostatic Neoplasms; Thiophenes | 2002 |
Matrix metalloproteinase activity, bone matrix turnover, and tumor cell proliferation in prostate cancer bone metastasis.
Topics: Animals; Antineoplastic Agents; Apoptosis; Bone Neoplasms; Bone Remodeling; Bone Transplantation; Calcium; Disease Models, Animal; Fetal Tissue Transplantation; Humans; Immunohistochemistry; In Situ Hybridization; Male; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Mice; Mice, SCID; Neoplasm Metastasis; Oligonucleotide Probes; Osteoclasts; Phenylalanine; Prostatic Neoplasms; RNA, Messenger; Thiophenes; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2002 |
Synthetic matrix metalloproteinase inhibitors inhibit growth of established breast cancer osteolytic lesions and prolong survival in mice.
Topics: Animals; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Cell Survival; Dipeptides; Female; Genetic Therapy; Humans; Matrix Metalloproteinase Inhibitors; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; Osteolysis; Phenylalanine; Protease Inhibitors; Thiophenes; Transfection; Transplantation, Heterologous; Tumor Cells, Cultured | 2002 |